It lives on your baby’s skin from birth. It builds the barrier, trains the immune system, and fights harmful pathogens. Most parents have never heard of it.
THE SHORT VERSION
Staphylococcus epidermidis is the most abundant beneficial bacterium on healthy human skin. Research has shown it actively produces ceramides for the skin barrier, primes the immune system, and inhibits Staphylococcus aureus colonization. It thrives in the mildly acidic pH range of healthy infant skin — and is disrupted when that pH shifts upward. Nest Prebiotic Baby Wipes deliver NatureBiome™ (inulin and alpha-glucan oligosaccharide) at pH 5.0–5.4 to selectively feed S. epidermidis and other beneficial skin commensals at every diaper change.
There is a bacterium on your baby’s skin right now doing work that no product can fully replicate.
Its name is Staphylococcus epidermidis. It is one of the most abundant bacterial colonizers of healthy human skin. For most of medical history it was considered unremarkable — a harmless bystander, present but not particularly consequential. Research over the past decade has shown that assumption was wrong. Significantly wrong.
S. epidermidis is not passive. It is one of the most active contributors to skin barrier health, immune education, and pathogen defense that we have identified in the skin microbiome. Understanding what it does — and what disrupts it — changes how we should think about every product that contacts infant skin.
What Does S. epidermidis Actually Do on Skin?
Research published over the past several years has progressively documented three distinct functions of S. epidermidis on healthy skin.
First, barrier reinforcement. S. epidermidis generates ceramides — the lipid molecules that form the structural foundation of the skin barrier. A healthy barrier retains moisture, resists irritants, and prevents pathogen entry. The microbiome is not simply living on the skin barrier. It is actively helping to build it.
Second, immune education. S. epidermidis primes the cutaneous immune response. It helps the immune system learn what belongs on the skin and what doesn’t. Early colonization in infancy — when the immune system is still forming — establishes the baseline for immune tolerance that persists into childhood.
Third, pathogen defense. S. epidermidis produces antimicrobial compounds — including phenol-soluble modulins and bacteriocins — that directly inhibit Staphylococcus aureus. S. aureus is the pathogen most associated with skin infections and atopic dermatitis flares. S. epidermidis competes with it for space, produces compounds that inhibit its biofilm formation, and suppresses its ability to establish on healthy skin.
“S. epidermidis is not simply living on the skin barrier. It is actively helping to build it.”
QUESTIONS ABOUT S. EPIDERMIDIS AND BABY SKIN
What is Staphylococcus epidermidis and why does it matter for babies?
Staphylococcus epidermidis (S. epidermidis) is the most abundant commensal bacterium on healthy human skin. In infants, it is one of the earliest and most consistent skin colonizers. Research has documented three key roles: it produces ceramides that reinforce the skin barrier, it primes the immune system during its formation window, and it produces antimicrobial compounds that inhibit pathogens like Staphylococcus aureus. Supporting this organism during infancy supports skin health at its biological foundation.
What disrupts S. epidermidis on baby skin?
S. epidermidis thrives in the mildly acidic pH range of healthy skin (4.5–5.5). When skin pH rises — through occlusion, exposure to urine and stool in the diaper area, or repeated contact with products formulated above this range — the conditions become less hospitable for commensals and more hospitable for opportunistic pathogens. Products applied 8+ times daily in the diaper area have a directional effect on this pH environment.
How do prebiotics support S. epidermidis?
S. epidermidis and related skin commensals selectively metabolize prebiotic oligosaccharides including inulin and alpha-glucan oligosaccharide — the two compounds in NatureBiome™. Laboratory research has shown these substrates selectively feed beneficial bacteria while not being metabolized by common skin pathogens in the same way. When fermented by commensals, these prebiotics produce lactic acid, which contributes to maintaining the acidic pH that S. epidermidis requires. The mechanism is self-reinforcing.
Why Is Infancy the Critical Window for S. epidermidis?
The skin microbiome of a newborn is actively assembling. The organisms that colonize in the first days and weeks — influenced by birth method, maternal microbiome, and skin contact — establish a community whose composition has lasting consequences. S. epidermidis is among the earliest and most consistent colonizers, establishing the barrier, immune, and pathogen-defense functions described above at exactly the time those systems are most plastic.
Research has shown that skin microbiome composition tends to stabilize and persist for up to two years in the absence of significant disruption. The ecosystem established in early life becomes the baseline. What supports or undermines it in those first months matters beyond those months.
Applied topically at a low pH matched to healthy infant skin, NatureBiome™ is the closest thing currently available to genuinely supporting this microbiome through a wipe — rather than simply doing it less harm.
———
This article is contributed by a guest researcher in skin microbiology. The Living Standard publishes independent educational content on the developing infant microbiome. Citations available on request.
